Mechanisms of vasculopathy in sickle cell disease and thalassemia.
about
Iron supplementation for sickle cell disease during pregnancyIron supplementation for sickle cell disease during pregnancyInterventions for treating leg ulcers in people with sickle cell diseaseSequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigsThe role of the arginine metabolome in pain: implications for sickle cell diseaseOxidative stress in β-thalassaemia and sickle cell diseaseEndothelin-1 but not Endothelial Nitric Oxide Synthase Gene Polymorphism is Associated with Sickle Cell Disease in AfricaDysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemiaThe critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis modelCXCL1 and its receptor, CXCR2, mediate murine sickle cell vaso-occlusion during hemolytic transfusion reactionsStroke in patients with sickle cell disease.Evidence for a novel mechanism independent of myocardial iron in β-thalassemia cardiac pathogenesis.Doppler velocimetry of the orbital arteries in patients with sickle cell anemia: relationship with biomarkers of hemolysis.Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism.Measurement of posttransfusion red cell survival with the biotin labelSickle cell disease: an opportunity for palliative care across the life span.Vascular endothelial dysfunction in β-thalassemia occurs despite increased eNOS expression and preserved vascular smooth muscle cell reactivity to NOA systematic comparison and evaluation of high density exon arrays and RNA-seq technology used to unravel the peripheral blood transcriptome of sickle cell disease.Iron metabolism in thalassemia and sickle cell diseaseLow bone mass density is associated with hemolysis in Brazilian patients with sickle cell disease.Selective enhancement of contractions to α1-adrenergic receptor activation in the aorta of mice with sickle cell disease.Hydroxyurea therapy mobilises arachidonic Acid from inner cell membrane aminophospholipids in patients with homozygous sickle cell diseasePeripheral vasoconstriction and abnormal parasympathetic response to sighs and transient hypoxia in sickle cell disease.Cre recombinase-regulated Endothelin1 transgenic mouse lines: novel tools for analysis of embryonic and adult disorders.Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network reportVasculature and kidney complications in sickle cell disease.Risk of erectile dysfunction in transfusion-naive thalassemia men: a nationwide population-based retrospective cohort studyN-acetylcysteine reduces oxidative stress in sickle cell patientsAssociation of Low Serum Iron with Alpha Globin Gene Deletions and High Level of HbF with Xmn-1 Polymorphism in Sickle Cell Traits.Prevalence of glutathione S-transferase gene deletions and their effect on sickle cell patients.Myocardial infarction in sickle cell disease: use of translational imaging to diagnose an under-recognized problemSildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertensionA randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodesMagnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia.Asthma management in sickle cell diseaseAsthma management: reinventing the wheel in sickle cell disease.Sickle cell anemia and vascular dysfunction: the nitric oxide connection.What's new in the pathophysiology of sickle cell disease?Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis.Triterpenoid inducers of Nrf2 signaling as potential therapeutic agents in sickle cell disease: a review.
P2860
Q24187693-74F14D98-C472-44BD-8931-1778D021FCD8Q24234773-7D9F1ABF-7264-4F59-AF7B-95757A958C62Q24239921-FA65A596-F5C1-4600-B3B5-BC9B5531E25FQ24657987-356372BD-8F26-4888-B0CF-023FBC9F726FQ26751338-1C3355DB-F72F-49FE-97F7-8A875B52AD16Q26797178-48E21BBA-9214-4803-B8F9-97D4CAD1928CQ28387609-45352C03-F056-49F9-B74F-E8A776B58FF9Q28395387-05E6FD5F-CC13-433D-8708-BBF6DDC69D18Q28512770-16B80690-4DA3-442F-B07A-E0859BEB0160Q30499303-A850D057-DAF2-44DE-B60E-9E2D7D234125Q30650303-EA36FD9C-03B2-45E7-85D8-44A2B3A935C2Q31110125-5EAFA395-06EA-46B8-A0AD-74E7A807E1F9Q33579761-E20B9496-982F-45C4-9BA4-FAF321F1629CQ33713601-29343835-E6A6-4881-8104-2FF83A8F509FQ34004336-27F3E5BB-B16A-4A13-AB36-7937425E6F24Q34100978-158F9182-8F2E-461C-98BD-E7273E0CA4B8Q34313817-032A9F00-0101-4425-AF4D-6C9E64C04EE2Q34322438-DB1CC991-1C96-4911-8645-634692766EADQ34549409-7E351A01-CC41-46AF-963E-469D0AFA08B2Q35028973-C5BA77F5-AF6B-4523-974E-1BD8B3A49069Q35092779-FA1478B7-DE97-4D84-9B8B-D28A4D9D1C15Q35215166-694C7DFC-7341-45DE-AE8F-E475A01BC2ACQ35219737-0A42BD81-F3A0-4DCA-B0E1-8E047A276921Q35268488-3EC3129D-6C35-46FA-8C8F-2C22B399FBB8Q35346284-6922C2BD-A721-4A0A-8225-30F372669F10Q35917528-3312D6A3-6471-4B44-89BD-96250C5173AFQ36009153-9DF860A8-E179-42C4-86CD-27F373802AB1Q36010842-E51B3150-ADF5-4769-98D9-B9653122B21BQ36079976-5E5AF08A-3C69-470B-BC35-2FA51CAC1E22Q36283148-F39E4963-5188-49B3-AA01-FA313BA295F7Q36673817-ACFB6422-3DA5-4173-B21A-FDDD0CD9A3BEQ37144856-91F1F070-B2BF-4262-A2B8-623293CEBB71Q37144863-5A14847C-C1DB-4B72-8066-1D451FFE63CDQ37178468-3299F1FA-1031-4FA5-96A2-D69CC7E65F90Q37346672-484EDF72-CBDD-4F0A-8238-DB16F7A13A82Q37396984-DFFC49A6-7E47-4986-A4C4-5EF165B28CCEQ37767680-B9CD2BBA-9F51-4595-893C-E9835BB70950Q38097639-E682A6D9-86DF-4DB1-B8D3-DA89A7F2D8EEQ38115527-484E5C32-6D0D-4475-A4DB-A8858D838236Q38289589-48500C02-80DB-43A6-920E-B36B87662C20
P2860
Mechanisms of vasculopathy in sickle cell disease and thalassemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanisms of vasculopathy in sickle cell disease and thalassemia.
@en
Mechanisms of vasculopathy in sickle cell disease and thalassemia.
@nl
type
label
Mechanisms of vasculopathy in sickle cell disease and thalassemia.
@en
Mechanisms of vasculopathy in sickle cell disease and thalassemia.
@nl
prefLabel
Mechanisms of vasculopathy in sickle cell disease and thalassemia.
@en
Mechanisms of vasculopathy in sickle cell disease and thalassemia.
@nl
P1476
Mechanisms of vasculopathy in sickle cell disease and thalassemia.
@en
P2093
Claudia R Morris
P304
P356
10.1182/ASHEDUCATION-2008.1.177
P577
2008-01-01T00:00:00Z